ABCG2 p.Lys473Ala

[switch to full view]
Comments [show]
Publications
PMID: 20203106 [PubMed] Cai X et al: "Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport."
No. Sentence Comment
2 Lys452 , Lys453 , His457 , Arg465 , and Lys473 were replaced with Ala or Asp.
X
ABCG2 p.Lys473Ala 20203106:2:40
status: VERIFIED
Login to comment

7 The transport activities and drug-resistance profiles of K473A were not changed.
X
ABCG2 p.Lys473Ala 20203106:7:57
status: VERIFIED
Login to comment

76 The polymerase chain reaction-based mutagenesis was performed according to the manufacturer`s instructions with the following forward primers: K452A (5Ј-gaa ctc ttt gtg gta gag GCg aag ctc ttc ata cat gaa-3Ј), K453D (5Ј-ctc ttt gtg gta gag aag GaC ctc ttc ata cat gaa tac-3Ј), H457A (5Ј-gag aag aag ctc ttc ata GCt gaa tac atc agc gga tac-3Ј), R465A (5Ј-tac atc agc gga tac tac GCa gtg tca tct tat ttc ctt-3Ј), and K473A (5Ј-tca tct tat ttc ctt gga GCa ctg tta tct gat tta tta-3Ј).
X
ABCG2 p.Lys473Ala 20203106:76:463
status: VERIFIED
Login to comment

177 To evaluate the role of these basic residues in BCRP activity, we generated mutants in which Lys452 , His457 , Arg465 , and Lys473 were replaced with Ala.
X
ABCG2 p.Lys473Ala 20203106:177:124
status: VERIFIED
Login to comment

183 The expression levels of the mutants K452A, K453D, H457A, R465A, and K473A, determined by immunoblotting of whole-cell lysates using beta-actin as an internal standard, were approximately 0.74-, 2.56-, 0.24-, 3.87-, and 1.56-fold that of wild-type BCRP (Fig. 2, A and B).
X
ABCG2 p.Lys473Ala 20203106:183:69
status: VERIFIED
Login to comment

191 A, a representative immunoblot of whole-cell lysates for wild-type BCRP and the mutants K452A, K453D, H457A, R465A, and K473A.
X
ABCG2 p.Lys473Ala 20203106:191:120
status: VERIFIED
Login to comment

208 Efflux activities of K473A were not significantly changed.
X
ABCG2 p.Lys473Ala 20203106:208:21
status: VERIFIED
Login to comment

220 After normalization to the BCRP levels, the IC50 values of cells expressing K452A, K453D, H457A, and R465A for MX and SN-38 were significantly different from those of cells expressing wild-type BCRP, whereas the IC50 values of cells expressing K473A and wild-type protein were comparable.
X
ABCG2 p.Lys473Ala 20203106:220:244
status: VERIFIED
Login to comment

232 The Km values of K453D, R465A, and K473A were comparable with that of wild-type protein; however, the Km values of K452A and H457A were decreased by approximately 50 and 70%, respectively, suggesting that these two mutations, particularly the one at position 457, increased the binding affinity of ATP to BCRP.
X
ABCG2 p.Lys473Ala 20203106:232:35
status: VERIFIED
Login to comment

235 As a result, the Vmax/Km values of K452A and H457A were increased approximately 210 µm 10 µm 10 µm Wild-type BCRP K452A K453D 10 µm 10 µm10 µm 10 µm H457A R465A K473A Fig. 3.
X
ABCG2 p.Lys473Ala 20203106:235:196
status: VERIFIED
Login to comment

241 Selected areas of HEK cells expressing wild-type BCRP and the mutants K452A, K453D, H457A, R465A, and K473A are shown.
X
ABCG2 p.Lys473Ala 20203106:241:102
status: VERIFIED
Login to comment

245 The Vmax/Km value of K473A was comparable with that of wild-type protein.
X
ABCG2 p.Lys473Ala 20203106:245:21
status: VERIFIED
Login to comment

263 Mitoxantrone BODIPY-Prazosin Hoechst33342 ⌬F ⌬FЈ Ratio ⌬F ⌬FЈ Ratio ⌬F ⌬FЈ Ratio pcDNA vector 0 0 0 0 0 0 Wild-type BCRP 11.1 Ϯ 1.5 11.1 Ϯ 1.5 1.0 49.9 Ϯ 13.1 49.9 Ϯ 13.1 1.0 976.5 Ϯ 115.5 976.5 Ϯ 115.5 1.0 K452A 22.0 Ϯ 5.9 29.7 Ϯ 7.9* 2.7 76.6 Ϯ 22.5 103.5 Ϯ 30.4* 2.1 1138.3 Ϯ 134.7 1538.3 Ϯ 182.1* 1.6 K453D 19.1 Ϯ 5.9 7.5 Ϯ 3.3* 0.7 57.7 Ϯ 15.6 22.6 Ϯ 6.1* 0.4 1116.9 Ϯ 132.2 436.3 Ϯ 51.6* 0.4 H457A 4.5 Ϯ 2.1 18.7 Ϯ 8.7* 1.7 40.1 Ϯ 9.7 167.0 Ϯ 40.2* 3.3 1259.5 Ϯ 343.2 5247.9 Ϯ 1429.9* 5.4 R465A 26.1 Ϯ 3.0 6.8 Ϯ 0.8* 0.6 96.5 Ϯ 16.0 24.9 Ϯ 4.1* 0.5 2217.8 Ϯ 255.2 573.1 Ϯ 65.9* 0.6 K473A 22.2 Ϯ 5.0 14.3 Ϯ 3.2 1.3 83.2 Ϯ 17.6 53.3 Ϯ 11.3 1.1 1411.5 Ϯ 166.8 887.7 Ϯ 104.9 0.9 no effect on phycoerythrin fluorescence.
X
ABCG2 p.Lys473Ala 20203106:263:828
status: VERIFIED
Login to comment

266 In contrast, prazosin only slightly decreased, rather than increased, the binding of 5D3 to K473A at low concentrations.
X
ABCG2 p.Lys473Ala 20203106:266:92
status: VERIFIED
Login to comment

268 Limited Trypsin Digestion of Wild-Type BCRP and the Mutants H457A and K473A.
X
ABCG2 p.Lys473Ala 20203106:268:70
status: VERIFIED
Login to comment

270 Therefore, to provide additional evidence of conformational changes in the BCRP mutants, we performed limited trypsin digestion of plasma membrane preparations of wild-type BCRP and two representative mutants H457A and K473A that showed significant changes in the pattern of 5D3 binding (Fig. 6).
X
ABCG2 p.Lys473Ala 20203106:270:219
status: VERIFIED
Login to comment

273 In contrast, significant trypsin cleavage of both H457A and K473A began to occur at a trypsin/protein ratio of 1:100 (Fig. 7, B and C).
X
ABCG2 p.Lys473Ala 20203106:273:60
status: VERIFIED
Login to comment

289 Vanadate-sensitive ATPase activities of wild-type and mutant BCRP were measured with plasma membrane preparations over an ATP concentration range of 0 to 5 mM as described. Shown are means Ϯ S.D. of three independent experiments for wild-type BCRP (f), K452A (), K453D (F), H457A (‚), R465A (ࡗ), and K473A (छ).
X
ABCG2 p.Lys473Ala 20203106:289:325
status: VERIFIED
Login to comment

297 MX SN-38 Dox Rho123 IC50 Relative Resistance (Ratio) IC50 Relative Resistance (Ratio) IC50 Relative Resistance IC50 Relative Resistance nM nM nM ␮M pcDNA vector 24.0 Ϯ 3.5 2.4 Ϯ 0.3 24.0 Ϯ 8.7 7.26 Ϯ 1.15 Wild-type BCRP 145.1 Ϯ 52.8 6.0 (1.0) 125.3 Ϯ 6.1 52.2 (1.0) 31.5 Ϯ 12.6 1.3 10.97 Ϯ 1.84 1.5 K452A 354.8 Ϯ 68.6 14.8 (3.3)* 103.0 Ϯ 12.5 42.9 (1.1)* 24.2 Ϯ 4.4 1.0 9.27 Ϯ 1.75 1.3 K453D 244.0 Ϯ 99.9 10.2 (0.7)* 136.2 Ϯ 9.9 56.8 (0.4)* 34.0 Ϯ 6.7 1.4 8.22 Ϯ 0.97 1.1 H457A 71.9 Ϯ 12.8 3.0 (2.1)* 90.6 Ϯ 4.6 37.8 (3.0)* 21.8 Ϯ 16.6 0.9 7.61 Ϯ 1.29 1.0 R465A 169.1 Ϯ 49.0 7.0 (0.3)* 224.2 Ϯ 39.7 93.4 (0.5)* 37.9 Ϯ 17.5 1.6 14.65 Ϯ 1.26 2.0 K473A 243.1 Ϯ 114.0 10.1 (1.1) 188.0 Ϯ 19.2 78.3 (0.9) 36.0 Ϯ 10.1 1.5 15.11 Ϯ 1.43 2.1 not Lys452 , Lys453 , and Lys473 , seem to directly participate in the binding of all four substrates.
X
ABCG2 p.Lys473Ala 20203106:297:795
status: VERIFIED
Login to comment

317 Wild-type BCRP K452A K453D H457A R465A K473A Vmax (nmol Pi/min/mg protein) 18.4 Ϯ 1.8 16.4 Ϯ 1.9 15.1 Ϯ 1.4 3.94 Ϯ 0.07 15.8 Ϯ 2.6 17.1 Ϯ 1.3 Vmax normalized to BCRP level (nmol Pi/min/mg protein) 18.4 Ϯ 1.8 18.4 Ϯ 2.1 7.4 Ϯ 0.7 19.6 Ϯ 0.3 6.7 Ϯ 1.1 17.6 Ϯ 1.3 Km for ATP (mM) 0.69 Ϯ 0.21 0.32 Ϯ 0.15 0.85 Ϯ 0.12 0.17 Ϯ 0.07 0.46 Ϯ 0.11 0.52 Ϯ 0.13 Vmax/Km (nmol Pi/min/mg protein/mM) 26.7 57.5 8.7 115.3 14.6 33.8 0 25 50 75 100 -0.25 0.00 0.25 0.50 0.75 1.00 1.25 Prazosin (µM) ∆F/F0 Fig. 6.
X
ABCG2 p.Lys473Ala 20203106:317:39
status: VERIFIED
Login to comment

319 The concentration-dependent effects of prazosin on the binding of 5D3 to wild-type and mutant BCRP over a concentration range of 0 to 100 ␮M were determined by using flow cytometry as described. Shown are means Ϯ S.D. of three independent experiments for the pcDNA control (f), wild-type BCRP (Œ), K452A (छ), K453D (ࡗ), H457A (F), R465A (Ⅺ), and K473A (‚).
X
ABCG2 p.Lys473Ala 20203106:319:384
status: VERIFIED
Login to comment

320 1 2 3 4 5 6 7 8 9 Wild-type BCRP 72 43 1 2 3 4 5 6 7 8 9 kDa 34 BCRP fraction: 1.0 1.0 0.9 0.9 0.9 0.7 0.6 0.09 0 72 1 2 3 4 5 6 7 8 9 H457A kDa 43 34 1 2 3 4 5 6 7 8 9 BCRP fraction: 1.0 1.4 1.3 1.3 1.5 1.4 0.5 0 0 K473A kDa 72 43 kDa 34 BCRP fraction: 1.0 1.2 1.0 0.9 0.9 0.9 0.8 0.05 0 Fig. 7.
X
ABCG2 p.Lys473Ala 20203106:320:216
status: VERIFIED
Login to comment

321 Trypsin digestion of wild-type BCRP, H457A, and K473A.
X
ABCG2 p.Lys473Ala 20203106:321:48
status: VERIFIED
Login to comment

322 Plasma membrane preparations expressing wild-type BCRP, H457A, or K473A (2 ␮g of protein each lane) were subjected to limited trypsin digestion and immunoblotting as described under Materials and Methods.
X
ABCG2 p.Lys473Ala 20203106:322:66
status: VERIFIED
Login to comment

331 Conversion of Lys473 to Ala had no significant effect on BCRP activity.
X
ABCG2 p.Lys473Ala 20203106:331:14
status: VERIFIED
Login to comment

375 Prazosin differentially increased 5D3 binding to wild-type BCRP, K452A, K453D, H457A, and R465A, but had little effect on 5D3 binding to K473A (Fig. 6).
X
ABCG2 p.Lys473Ala 20203106:375:137
status: VERIFIED
Login to comment

379 K473A appears to be the case that revealed a completely different pattern of 5D3 binding (Fig. 6) and increased resistance to trypsin digestion (Fig. 7) compared with wild-type protein, but showed no activity changes.
X
ABCG2 p.Lys473Ala 20203106:379:0
status: VERIFIED
Login to comment

PMID: 20812902 [PubMed] Ni Z et al: "Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)."
No. Sentence Comment
314 Such mutants include K473A and H630X, suggesting that these residues are likely not critical for expression and function of BCRP.
X
ABCG2 p.Lys473Ala 20812902:314:21
status: VERIFIED
Login to comment

PMID: 26294421 [PubMed] Haider AJ et al: "Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences."
No. Sentence Comment
109 We made individual substitutions of each amino acid to alanine: M131A, S195A, K453A, K473A, P485A, M549A, W564A and I573A.
X
ABCG2 p.Lys473Ala 26294421:109:85
status: NEW
Login to comment

153 Firstly, there was a group of five mutants which showed FTC-inhibited MX export comparable to WT protein (e.g. M131A, S195A, K453A, K473A, W564A; M131A data shown in Figure 3C).
X
ABCG2 p.Lys473Ala 26294421:153:132
status: NEW
Login to comment